Anavex Life Sciences
AVXL
#9652
Rank
NZ$0.20 B
Marketcap
NZ$2.17
Share price
6.09%
Change (1 day)
-81.22%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2023 (TTM): NZ-$1.09

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.27. In 2022 the company made an earnings per share (EPS) of NZ-$1.15 a decrease over its 2021 EPS that were of NZ-$0.98.

EPS history for Anavex Life Sciences from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$1.09-5.84%
2022NZ-$1.1518.18%
2021NZ-$0.9822.22%
2020NZ-$0.80-11.76%
2019NZ-$0.9110.87%
2018NZ-$0.8235.29%
2017NZ-$0.60-10.53%
2016NZ-$0.67-39.41%
2015NZ-$1.11-45.94%
2014NZ-$2.06180.17%
2013NZ-$0.74-50.71%
2012NZ-$1.49-22.22%
2011NZ-$1.92-28.95%
2010NZ-$2.7058.33%
2009NZ-$1.70-11.11%
2008NZ-$1.92107.69%
2007NZ-$0.92
2006N/A-100%
2005NZ-$0.02738

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$17.77-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.92-446.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$13.41 4,933.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.56 860.00%๐Ÿ‡บ๐Ÿ‡ธ USA